PT Charlie Hospital Semarang Tbk (IDX:RSCH)
Indonesia · Delayed Price · Currency is IDR 278.00
0.00 (0.00%)
Last updated: Apr 28, 2026, 2:58 PM WIB
IDX:RSCH Revenue
In the year 2025, PT Charlie Hospital Semarang Tbk had annual revenue of 114.40B IDR with 135.86% growth. PT Charlie Hospital Semarang Tbk had revenue of 67.81B in the quarter ending December 31, 2025, with 453.44% growth.
Revenue
114.40B
Revenue Growth
+135.86%
P/S Ratio
6.44
Revenue / Employee
539.61M
Employees
212
Market Cap
736.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 114.40B | 65.89B | 135.86% |
| Dec 31, 2024 | 48.50B | 6.34B | 15.04% |
| Dec 31, 2023 | 42.16B | 9.13B | 27.63% |
| Dec 31, 2022 | 33.03B | -2.52B | -7.10% |
| Dec 31, 2021 | 35.56B | 22.29B | 168.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Lippo Karawaci Tbk | 8.84T |
| PT Medikaloka Hermina Tbk | 7.13T |
| PT Mitra Keluarga Karyasehat Tbk | 5.37T |
| PT Famon Awal Bros Sedaya Tbk | 2.44T |
| PT Sarana Meditama Metropolitan Tbk | 1.86T |
| PT Bundamedik Tbk | 1.61T |
| PT Murni Sadar Tbk | 1.36T |
| PT Kedoya Adyaraya Tbk | 469.59B |